Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | 17-AAG | 0.031623 | uM | 10 | 2500.00 | 1067.09 | 5381.00 | 5130.00 | 1.0489 | 1.0426 |
MDA-MB-231 | Erlotinib | 0.1 | uM | 10 | 2500.00 | 1067.09 | 5449.00 | 5130.00 | 1.0622 | 1.0540 |
MDA-MB-231 | 0 | uM | 10 | 2500.00 | 1067.09 | 5417.00 | 5130.00 | 1.0559 | 1.0486 | |
MDA-MB-231 | Linsitinib | 0.1 | uM | 10 | 2500.00 | 1067.09 | 5360.00 | 5130.00 | 1.0448 | 1.0391 |
MDA-MB-231 | Lapatinib | 0.0016596 | uM | 10 | 2500.00 | 1067.09 | 5532.00 | 5130.00 | 1.0784 | 1.0677 |
MDA-MB-231 | Lapatinib | 0.0033113 | uM | 10 | 2500.00 | 1067.09 | 5367.00 | 5130.00 | 1.0462 | 1.0403 |
MDA-MB-231 | Linsitinib | 1 | uM | 10 | 2500.00 | 1067.09 | 5183.00 | 5130.00 | 1.0103 | 1.0091 |
MDA-MB-231 | Lapatinib | 0.01 | uM | 10 | 2500.00 | 1067.09 | 5574.00 | 5130.00 | 1.0865 | 1.0746 |
MDA-MB-231 | Linsitinib | 0.031623 | uM | 10 | 2500.00 | 1067.09 | 5619.00 | 5130.00 | 1.0953 | 1.0820 |
MDA-MB-231 | 17-AAG | 1 | uM | 10 | 2500.00 | 1067.09 | 3817.00 | 5130.00 | 0.7441 | 0.7553 |
MDA-MB-231 | 0 | uM | 10 | 2500.00 | 1067.09 | 5196.00 | 5130.00 | 1.0129 | 1.0113 | |
MDA-MB-231 | Lapatinib | 0.1 | uM | 10 | 2500.00 | 1067.09 | 5240.00 | 5130.00 | 1.0214 | 1.0188 |
MDA-MB-231 | Lapatinib | 0.031623 | uM | 10 | 2500.00 | 1067.09 | 5089.00 | 5130.00 | 0.9920 | 0.9929 |
MDA-MB-231 | 0 | uM | 10 | 2500.00 | 1067.09 | 5052.00 | 5130.00 | 0.9848 | 0.9865 | |
MDA-MB-231 | 0 | uM | 10 | 5000.00 | 2314.91 | 6209.00 | 6615.25 | 0.9386 | 0.9181 | |
MDA-MB-231 | 17-AAG | 3.1623 | uM | 10 | 5000.00 | 2314.91 | 3377.00 | 6615.25 | 0.5105 | 0.2831 |
MDA-MB-231 | Erlotinib | 0.01 | uM | 10 | 5000.00 | 2314.91 | 6355.00 | 6615.25 | 0.9607 | 0.9477 |
MDA-MB-231 | Linsitinib | 3.1623 | uM | 10 | 5000.00 | 2314.91 | 5829.00 | 6615.25 | 0.8812 | 0.8397 |
MDA-MB-231 | Erlotinib | 0.0033113 | uM | 10 | 5000.00 | 2314.91 | 6574.00 | 6615.25 | 0.9938 | 0.9918 |
MDA-MB-231 | Lapatinib | 10 | uM | 10 | 5000.00 | 2314.91 | 5301.00 | 6615.25 | 0.8013 | 0.7280 |
MDA-MB-231 | Linsitinib | 0.0033113 | uM | 10 | 5000.00 | 2314.91 | 6637.00 | 6615.25 | 1.0033 | 1.0043 |
MDA-MB-231 | Erlotinib | 3.1623 | uM | 10 | 5000.00 | 2314.91 | 6617.00 | 6615.25 | 1.0003 | 1.0003 |
MDA-MB-231 | Lapatinib | 1 | uM | 10 | 5000.00 | 2314.91 | 6594.00 | 6615.25 | 0.9968 | 0.9958 |
MDA-MB-231 | Lapatinib | 0.31623 | uM | 10 | 5000.00 | 2314.91 | 6849.00 | 6615.25 | 1.0353 | 1.0464 |
MDA-MB-231 | Erlotinib | 10 | uM | 10 | 5000.00 | 2314.91 | 6282.00 | 6615.25 | 0.9496 | 0.9329 |